相似文献
1
Adrenomedullin up-regulates osteopontin and attenuates vascular calcification via the cAMP/PKA signaling pathway.
Acta Pharmacol Sin. 2010 Oct;31(10):1359-66. doi: 10.1038/aps.2010.89. Epub 2010 Aug 30.
2
C-type natriuretic peptide inhibiting vascular calcification might involve decreasing bone morphogenic protein 2 and osteopontin levels.
Mol Cell Biochem. 2014 Jul;392(1-2):65-76. doi: 10.1007/s11010-014-2019-1. Epub 2014 Apr 8.
3
Hydrogen sulfide ameliorates vascular calcification induced by vitamin D3 plus nicotine in rats.
Acta Pharmacol Sin. 2006 Mar;27(3):299-306. doi: 10.1111/j.1745-7254.2006.00283.x.
4
Effects of adrenomedullin, C-type natriuretic peptide, and parathyroid hormone-related peptide on calcification in cultured rat vascular smooth muscle cells.
J Cardiovasc Pharmacol. 2003 Jul;42(1):89-97. doi: 10.1097/00005344-200307000-00014.
5
Adrenomedullin(27-52) inhibits vascular calcification in rats.
Regul Pept. 2005 Jul 15;129(1-3):125-32. doi: 10.1016/j.regpep.2005.02.017.
6
Intermedin1-53 attenuates vascular smooth muscle cell calcification by inhibiting endoplasmic reticulum stress via cyclic adenosine monophosphate/protein kinase A pathway.
Exp Biol Med (Maywood). 2013 Oct;238(10):1136-46. doi: 10.1177/1535370213502619. Epub 2013 Sep 4.
7
[Effect of age on vascular calcification induced by vitamin D3 and nicotine].
Beijing Da Xue Xue Bao Yi Xue Ban. 2010 Apr 18;42(2):131-6.
8
Activating BK channels ameliorates vascular smooth muscle calcification through Akt signaling.
Acta Pharmacol Sin. 2022 Mar;43(3):624-633. doi: 10.1038/s41401-021-00704-6. Epub 2021 Jun 23.
9
Intermedin inhibits vascular calcification by increasing the level of matrix gamma-carboxyglutamic acid protein.
Cardiovasc Res. 2010 Mar 1;85(4):864-73. doi: 10.1093/cvr/cvp366. Epub 2009 Nov 12.
10
The role of adrenomedullin and its receptor system in cardiovascular calcification of rat induced by Vitamin D(3) plus nicotine.
Peptides. 2004 Apr;25(4):601-8. doi: 10.1016/j.peptides.2004.02.020.
引用本文的文献
1
Isoforskolin modulates AQP4-SPP1-PIK3C3 related pathway for chronic obstructive pulmonary disease via cAMP signaling.
Chin Med. 2023 Oct 10;18(1):128. doi: 10.1186/s13020-023-00778-w.
2
Osteopontin - The stirring multifunctional regulatory factor in multisystem aging.
Front Endocrinol (Lausanne). 2022 Dec 22;13:1014853. doi: 10.3389/fendo.2022.1014853. eCollection 2022.
3
Flavocoxid Ameliorates Aortic Calcification Induced by Hypervitaminosis D and Nicotine in Rats Via Targeting TNF-α, IL-1β, iNOS, and Osteogenic Runx2.
Cardiovasc Drugs Ther. 2022 Dec;36(6):1047-1059. doi: 10.1007/s10557-021-07227-6. Epub 2021 Jul 26.
4
Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.
Toxins (Basel). 2020 Sep 29;12(10):624. doi: 10.3390/toxins12100624.
5
Adrenomedullin Attenuates Inflammation in White Adipose Tissue of Obese Rats Through Receptor-Mediated PKA Pathway.
Obesity (Silver Spring). 2021 Jan;29(1):86-97. doi: 10.1002/oby.23012. Epub 2020 Sep 28.
6
Regulation of Vascular Calcification by Growth Hormone-Releasing Hormone and Its Agonists.
Circ Res. 2018 May 11;122(10):1395-1408. doi: 10.1161/CIRCRESAHA.117.312418. Epub 2018 Apr 4.
7
Hydrogen Sulfide Facilitates the Impaired Sensitivity of Carotid Sinus Baroreflex in Rats with Vascular Calcification.
Front Pharmacol. 2017 Sep 12;8:629. doi: 10.3389/fphar.2017.00629. eCollection 2017.
8
A Lindera obtusiloba Extract Blocks Calcium-/Phosphate-Induced Transdifferentiation and Calcification of Vascular Smooth Muscle Cells and Interferes with Matrix Metalloproteinase-2 and Metalloproteinase-9 and NF-κB.
Evid Based Complement Alternat Med. 2015;2015:679238. doi: 10.1155/2015/679238. Epub 2015 Jul 30.
9
Magnesium modulates the expression levels of calcification-associated factors to inhibit calcification in a time-dependent manner.
Exp Ther Med. 2015 Mar;9(3):1028-1034. doi: 10.3892/etm.2015.2215. Epub 2015 Jan 26.
10
C-type natriuretic peptide inhibiting vascular calcification might involve decreasing bone morphogenic protein 2 and osteopontin levels.
Mol Cell Biochem. 2014 Jul;392(1-2):65-76. doi: 10.1007/s11010-014-2019-1. Epub 2014 Apr 8.
本文引用的文献
1
Intermedin inhibits vascular calcification by increasing the level of matrix gamma-carboxyglutamic acid protein.
Cardiovasc Res. 2010 Mar 1;85(4):864-73. doi: 10.1093/cvr/cvp366. Epub 2009 Nov 12.
2
Association of plasma osteopontin levels with coronary calcification evaluated by tomographic coronary calcium scoring.
J Bone Miner Metab. 2009;27(5):591-7. doi: 10.1007/s00774-009-0078-2. Epub 2009 Apr 14.
3
Vascular calcification: pathobiology of a multifaceted disease.
Circulation. 2008 Jun 3;117(22):2938-48. doi: 10.1161/CIRCULATIONAHA.107.743161.
4
Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification.
J Mol Med (Berl). 2008 Apr;86(4):379-89. doi: 10.1007/s00109-007-0294-y. Epub 2007 Dec 15.
5
Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification.
J Thromb Haemost. 2007 Dec;5(12):2503-11. doi: 10.1111/j.1538-7836.2007.02758.x. Epub 2007 Sep 10.
6
Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease.
Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2302-9. doi: 10.1161/ATVBAHA.107.144824. Epub 2007 Aug 23.
7
Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migration.
Cardiovasc Res. 2007 Sep 1;75(4):738-47. doi: 10.1016/j.cardiores.2007.05.019. Epub 2007 May 24.
8
Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice.
J Histochem Cytochem. 2007 Apr;55(4):375-86. doi: 10.1369/jhc.6A7087.2006. Epub 2006 Dec 22.
9
Osteopontin and cardiovascular system.
Mol Cell Biochem. 2007 Jun;300(1-2):1-7. doi: 10.1007/s11010-006-9368-3. Epub 2006 Nov 30.
10
Vascular calcification: pathobiological mechanisms and clinical implications.
Circ Res. 2006 Nov 10;99(10):1044-59. doi: 10.1161/01.RES.0000249379.55535.21.
Zotero 插件